Author

A. Rosende

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Effectiveness and safety of a New Standardised TrEatment Protocol based on initial/early therapy with single-pill combinations of blood pressure-lowering drugs for improving blood pressure control (NewSTeP): Rationale, design of a randomized clinical trial and baseline characteristics of the trial p

Background Hypertension is the leading modifiable risk factor for cardiovascular disease (CVD). Despite availability of blood pressure (BP)-lowering therapies, BP control rates remain suboptimal. Reluctance to initiate treatment with combination therapy and delayed treatment intensification contribute to poor control....

R. Dhurjati, R. Pant, A. Kumar et al. · medRxiv · 0 citations

Open access Sep 2026

Stroke Burden Attributable to Risk Factors in the Americas, 1990 to 2021: A Temporal Trends Analysis From the GBD Study 2021.

BACKGROUND Stroke burden varies across the Americas, yet data on modifiable risk factor contributions remain limited. METHODS Using GBD (Global Burden of Disease) study 2021 data, we analyzed stroke mortality and disability-adjusted life-year (DALY) rates attributable to 23 modifiable risk factors across 39 countries...

Felipe Fregni, B. Almarie, Ramón Martínez et al. · Journal of the American Hear... · 0 citations